These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34316300)

  • 1. Remission of Pediatric Diffuse Intrinsic Pontine Glioma: Case Report and Review of the Literature.
    Espirito Santo V; Passos J; Nzwalo H; Nunes S; Salgado D
    J Pediatr Neurosci; 2021; 16(1):1-4. PubMed ID: 34316300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review.
    Navarro RE; Golub D; Hill T; McQuinn MW; William C; Zagzag D; Hidalgo ET
    Childs Nerv Syst; 2021 Jul; 37(7):2347-2356. PubMed ID: 32989496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review.
    De Martino L; Picariello S; Russo C; Errico ME; Spennato P; Papa MR; Normanno N; Scimone G; Colafati GS; Cacchione A; Mastronuzzi A; Massimino M; Cinalli G; Quaglietta L
    Front Mol Neurosci; 2023; 16():1152430. PubMed ID: 37547920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord.
    Gu Q; Huang Y; Zhang H; Jiang B
    Front Oncol; 2021; 11():701113. PubMed ID: 34956856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.
    Persson ML; Douglas AM; Alvaro F; Faridi P; Larsen MR; Alonso MM; Vitanza NA; Dun MD
    Neuro Oncol; 2022 Sep; 24(9):1408-1422. PubMed ID: 35481923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review.
    Hashii Y; Oka Y; Kagawa N; Hashimoto N; Saitou H; Fukuya S; Kanegae M; Ikejima S; Oji Y; Ozono K; Tsuboi A; Sugiyama H
    Front Oncol; 2020; 10():1188. PubMed ID: 32793489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffuse midline glioma].
    Saito R
    No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.
    Vallero SG; Bertero L; Morana G; Sciortino P; Bertin D; Mussano A; Ricci FS; Peretta P; Fagioli F
    Front Oncol; 2022; 12():1082062. PubMed ID: 36727064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.
    Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS
    Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1.
    Yoon HI; Wee CW; Kim YZ; Seo Y; Im JH; Dho YS; Kim KH; Hong JB; Park JS; Choi SH; Kim MS; Moon J; Hwang K; Park JE; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Sung KS; Song JH; Lee MH; Han MH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
    Brain Tumor Res Treat; 2021 Apr; 9(1):1-8. PubMed ID: 33913265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases.
    Jang SW; Song SW; Kim YH; Cho YH; Hong SH; Kim JH; Ra YS; Chong S
    Brain Tumor Res Treat; 2022 Oct; 10(4):255-264. PubMed ID: 36347640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma.
    Miguel Llordes G; Medina Pérez VM; Curto Simón B; Castells-Yus I; Vázquez Sufuentes S; Schuhmacher AJ
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629304
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
    Jiang H; Yang K; Ren X; Cui Y; Li M; Lei Y; Lin S
    Neuro Oncol; 2020 May; 22(5):e1-e9. PubMed ID: 31504810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient.
    Cheng R; Li DP; Zhang N; Zhang JY; Zhang D; Liu TT; Yang J; Ge M
    Front Surg; 2021; 8():616334. PubMed ID: 34222313
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases.
    Yabuno S; Kawauchi S; Umakoshi M; Uneda A; Fujii K; Ishida J; Otani Y; Hattori Y; Tsuboi N; Kohno S; Noujima M; Toji T; Yanai H; Yasuhara T; Date I
    NMC Case Rep J; 2021; 8(1):505-511. PubMed ID: 35079510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting outcome in childhood diffuse midline gliomas using magnetic resonance imaging based texture analysis.
    Szychot E; Youssef A; Ganeshan B; Endozo R; Hyare H; Gains J; Mankad K; Shankar A
    J Neuroradiol; 2021 Jun; 48(4):243-247. PubMed ID: 32184119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular Cerebrospinal Fluid Sampling in Pediatric Diffuse Midline Glioma Patients: Institutional Experience and Review of the Literature.
    Li D; Stellpflug W; Romanski K; Kilgallon M; Speck S; Saratsis AM
    Front Pediatr; 2020; 8():556802. PubMed ID: 33194892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinicopathological characteristics of H3K27-altered diffuse midline glioma and evaluation of NTRK as its therapeutic target].
    Duan ZJ; Feng J; Yao K; Hu ZJ; Ma Z; Xiang L; Zhang XF; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Nov; 51(11):1115-1122. PubMed ID: 36323540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.